NASDAQ · AIRE

reAlpha Tech Corp.

$1.38 -$0.18 (-11.54%) 1D After hours

Key Metrics

$8.37M
Market cap
P/E · TTM
$4.43M
Revenue · TTM
−$19.08M
Net income
EPS · TTM $-0.42
Dividend yield
Free cash flow −$12.20M
Beta · 1Y 2.67
EBITDA · TTM −$17.29M
Gross margin 56.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 22
    From its Jan 29 high, the share price fell 87%.

    Peak close $9.94 on Jan 29; trough close $1.27 on Jul 22. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -87%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 30
    The stock moved -23.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 30
  • Apr 28
    The stock moved -33.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 28

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$8.37M
Enterprise value
Shares outstanding5.4M
52-wk range$0.31 – $13.74
Avg volume · 20D5.6M
Net cash
Book value / share$0.18
IndustryReal Estate
ExchangeNASDAQ
About reAlpha Tech Corp.
IPO dateOct 23, 2023
Employees54

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.89
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 56.0%
Operating -402.9%
Net -430.4%
FCF -275.1%
ROE / ROIC -389.3% · —

Financial Health

Current ratio2.13
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$3.10M

Cash Flow · TTM

Operating CF −$12.12M
Capex −$76.57K
Free cash flow −$12.20M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-7.1
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings